Close this search box.

Is there a Role for Pharmacoepidemilogy in Deprescribing Research?

October 6, 2022   |  12:00 – 1:00 PM Eastern / 9:00 – 10:00 AM Pacific


The session, hosted by the International Society for Pharmacoepidemiology (ISPE), will begin with a brief introduction of the topic and the speakers (moderators, 4-5 min, Drs. Andrew Zullo & Daniela Moga) followed by presentations to address:

  1. The existing deprescribing landscape (including existing deprescribing networks throughout the world), current initiatives in clinical and implementation deprescribing research, and the need to incorporate real-world data and observational studies (Dr. Caroline Sirois, 12 min)
  2. Recent efforts in operationalizing key variables needed for deprescribing studies using routinely generated healthcare data, including harmonizing measures across different healthcare systems and data types: finding from the US Deprescribing Research Network Data Harmonization Workgroup (Dr. Sascha Dublin, 12 min)
  3. Challenges and opportunities in using pharmacoepidemiologic approaches in deprescribing research (Dr. Anton Pottegård, 12 min)

The session will conclude with a call for methodology development and finding ways for data integration to facilitate observational deprescribing research under a causal framework (moderators, 5 min) followed by a Q&A session.

Co-sponsored by the US Deprescribing Research Network (USDeN) and Australian Deprescribing Network (ADeN).

Register Here »

Contact Us

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.